Literature DB >> 35858101

Interplay between the oxytocin and opioid systems in regulating social behaviour.

Philip T Putnam1, Steve W C Chang1,2,3,4.   

Abstract

The influence of neuromodulators on brain activity and behaviour is undeniably profound, yet our knowledge of the underlying mechanisms, or ability to reliably reproduce effects across varying conditions, is still lacking. Oxytocin, a hormone that acts as a neuromodulator in the brain, is an example of this quandary; it powerfully shapes behaviours across nearly all mammalian species, yet when manipulated exogenously can produce unreliable or sometimes unexpected behavioural results across varying contexts. While current research is rapidly expanding our understanding of oxytocin, interactions between oxytocin and other neuromodulatory systems remain underappreciated in the current literature. This review highlights interactions between oxytocin and the opioid system that serve to influence social behaviour and proposes a parallel-mechanism hypothesis to explain the supralinear effects of combinatorial neuropharmacological approaches. This article is part of the theme issue 'Interplays between oxytocin and other neuromodulators in shaping complex social behaviours'.

Entities:  

Keywords:  combinatorial; naloxone; neuromodulator; opioid; oxytocin; social behaviour

Mesh:

Substances:

Year:  2022        PMID: 35858101      PMCID: PMC9272147          DOI: 10.1098/rstb.2021.0050

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.671


  175 in total

1.  Endogenous opioids: do they modulate the rat pup's response to social isolation?

Authors:  J T Winslow; T R Insel
Journal:  Behav Neurosci       Date:  1991-04       Impact factor: 1.912

2.  Social Laughter Triggers Endogenous Opioid Release in Humans.

Authors:  Sandra Manninen; Lauri Tuominen; Robin I Dunbar; Tomi Karjalainen; Jussi Hirvonen; Eveliina Arponen; Riitta Hari; Iiro P Jääskeläinen; Mikko Sams; Lauri Nummenmaa
Journal:  J Neurosci       Date:  2017-05-23       Impact factor: 6.167

3.  A Cortical Circuit for Sexually Dimorphic Oxytocin-Dependent Anxiety Behaviors.

Authors:  Kun Li; Miho Nakajima; Ines Ibañez-Tallon; Nathaniel Heintz
Journal:  Cell       Date:  2016-09-15       Impact factor: 41.582

4.  Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala.

Authors:  Daniel Huber; Pierre Veinante; Ron Stoop
Journal:  Science       Date:  2005-04-08       Impact factor: 47.728

Review 5.  Social effects of oxytocin in humans: context and person matter.

Authors:  Jennifer A Bartz; Jamil Zaki; Niall Bolger; Kevin N Ochsner
Journal:  Trends Cogn Sci       Date:  2011-06-21       Impact factor: 20.229

6.  Promoting social behavior with oxytocin in high-functioning autism spectrum disorders.

Authors:  Elissar Andari; Jean-René Duhamel; Tiziana Zalla; Evelyn Herbrecht; Marion Leboyer; Angela Sirigu
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-16       Impact factor: 11.205

7.  Is there a Publication Bias in Behavioural Intranasal Oxytocin Research on Humans? Opening the File Drawer of One Laboratory.

Authors:  A Lane; O Luminet; G Nave; M Mikolajczak
Journal:  J Neuroendocrinol       Date:  2016-04       Impact factor: 3.627

8.  The emergence of the vasopressin and oxytocin hormone receptor gene family lineage: Clues from the characterization of vasotocin receptors in the sea lamprey (Petromyzon marinus).

Authors:  Sally A Mayasich; Benjamin L Clarke
Journal:  Gen Comp Endocrinol       Date:  2016-01-04       Impact factor: 2.822

9.  Plasma and CSF oxytocin levels after intranasal and intravenous oxytocin in awake macaques.

Authors:  Sara M Freeman; Sridhar Samineni; Philip C Allen; Diane Stockinger; Karen L Bales; Granger G C Hwa; Jeffrey A Roberts
Journal:  Psychoneuroendocrinology       Date:  2016-01-18       Impact factor: 4.905

Review 10.  Imaging of opioid receptors in the central nervous system.

Authors:  Gjermund Henriksen; Frode Willoch
Journal:  Brain       Date:  2007-11-29       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.